{
  "event_id": "c8dff8c1e93a",
  "ticker": "AMGN",
  "company_name": "Amgen",
  "drug_name": "REPATHA",
  "result": "approved",
  "pdufa_date": "2015-08-27",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:FOURIER trial",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.106432",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Hypercholesterolemia",
    "source": "websearch:FOURIER trial",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.106435",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "evolocumab",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Cardiovascular",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.449448",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "PCSK9 inhibitor",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.012585",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:FOURIER trial",
    "confidence": 0.95,
    "evidence": [
      "FOURIER trial"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.106416",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "<0.001",
    "source": "websearch:FOURIER trial",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.106424",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "59% LDL-C reduction",
    "source": "websearch:FOURIER trial",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.106428",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "p_value_numeric": 0.001,
  "nct_ids": [
    "NCT01764633",
    "NCT02207634"
  ],
  "phase3_study_names": [
    "A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease",
    "A Double-Blind, Placebo Controlled, Multicenter Study to Assess the Effect of Evolocumab on Cognitive Function in Patients With Clinically Evident Cardiovascular Disease and Receiving Statin Background Lipid Lowering Therapy: A Study for Subjects Enrolled in the FOURIER (Study 20110118) Trial"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "count": 27564,
    "type": "ACTUAL",
    "nct_id": "NCT01764633",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:44.543084"
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": false,
    "accelerated_approval": false
  },
  "adcom_info": {
    "scheduled": true,
    "held": true,
    "date": null,
    "outcome": "favorable",
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:35.430349",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['UKRAINE', 'INDIA', 'PHILIPPINES', 'ARGENTINA', 'AUSTRALIA']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:35.430523",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "known_originators_db",
    "confidence": 0.95,
    "tier": 1,
    "evidence": [
      "originator: repatha"
    ],
    "searched_sources": [
      "known_db",
      "patterns",
      "suffix_pattern",
      "approval_type"
    ],
    "last_searched": "2026-01-10T23:29:31.262901",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": "2014-01-27",
    "status": "found",
    "source": "fda.gov",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "Thousand Oaks CA facility - drug/device combo violations (Prolia, Enbrel prefilled syringes)"
    ],
    "searched_sources": [
      "fda.gov"
    ],
    "last_searched": "2026-01-11T04:05:14.881844",
    "error": null,
    "note": null
  },
  "fda_483_date": {
    "value": "2023-05-01",
    "status": "found",
    "source": "redica.com",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: Thousand Oaks, CA",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "redica.com"
    ],
    "last_searched": "2026-01-11T05:25:26.299168",
    "error": null,
    "facility": "Thousand Oaks, CA"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:30:55.911751",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:30:56.873846",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -3789,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.232975",
  "original_case_id": "829e170c103e",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:39:56.408650",
  "enriched_at": "2026-01-11T17:33:00.596104",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.012606",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "US FDA advisory panel votes for approval of Amgen’s PCSK9 ...",
      "Repatha (evolocumab) FDA Approval History - Drugs.com 125522_Review Package - accessdata.fda.gov REP",
      "Vote ratio extracted: 73.3%"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:00.596094"
  },
  "adcom_vote_ratio": {
    "value": 0.7333333333333333,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [
      "US FDA advisory panel votes for approval of Amgen’s PCSK9 ...",
      "Repatha (evolocumab) FDA Approval History - Drugs.com 125522_Review Package - accessdata.fda.gov REP",
      "Vote ratio extracted: 73.3%"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:00.596101"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:37.334298",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Amgen's sBLA for Repatha gets US FDA priority review status"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:46.580482",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Long-term benefit of Amgen’s Repatha in reducing MACE shown ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:47.741938",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Repatha (evolocumab) FDA Approval History - Drugs.com Review - Food and Drug Administration Repatha "
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:41.913451",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:54.422245",
    "search_status": "CONFIRMED_NONE"
  }
}